This inventor holds 4 USPTO granted patents. Top assignee: Millennium Pharmaceuticals Limited. Active years: 1999-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2005
Title: The Innovations of Xun Weng
Introduction
Xun Weng is a notable inventor based in Needham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of glucose transport. With a total of four patents to his name, Weng's work has implications for the diagnosis and treatment of various disorders.
Latest Patents
One of Weng's latest patents is titled "Nucleic acid molecules encoding GLUTX and uses thereof." This invention concerns the human gene encoding GLUTX, a glucose transporter. The GLUTX nucleic acid and polypeptides, as well as molecules that can increase or decrease the expression or activity of GLUTX, are useful in diagnosing and treating disorders associated with aberrant hexose transport. This innovative work highlights the potential for advancements in medical treatments related to glucose metabolism.
Career Highlights
Weng has been associated with Millennium Pharmaceuticals Limited, where he has contributed to various research initiatives. His expertise in molecular biology and genetics has positioned him as a key figure in the development of therapeutic solutions.
Collaborations
Weng has worked alongside Louis Anthony Tartaglia, collaborating on projects that leverage their combined expertise in biotechnology and pharmaceuticals.
Conclusion
Xun Weng's contributions to the field of biotechnology, particularly through his patents related to GLUTX, demonstrate his commitment to advancing medical science. His work continues to pave the way for innovative treatments in glucose-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile